医学
丙酸氟替卡松
中止
内科学
沙美特罗
福莫特罗
倾向得分匹配
哮喘
皮质类固醇
布地奈德/福莫特罗
布地奈德
作者
Carlyne M. Averell,Richard H. Stanford,François Laliberté,Jennifer W. Wu,Guillaume Germain,Mei Sheng Duh
标识
DOI:10.1080/02770903.2019.1663429
摘要
In this real-world study, patients initiating FF/VI had better adherence and lower risk of discontinuing treatment versus B/F or FP/SAL, suggesting that once-daily ICS/LABA treatment might improve adherence and persistence compared with twice-daily alternatives.
科研通智能强力驱动
Strongly Powered by AbleSci AI